The North America veterinary vaccines market growth is predicted to progress at a CAGR of 6.82% during the forecast period, 2022-2030, and generate a revenue of $5059.29 million by 2030.
NORTH AMERICA VETERINARY VACCINES MARKET FORECAST 2022-2030
North America Veterinary Vaccines Market by Animal Type (Livestock Animal, Companion Animal, Aquaculture) Market by Product Type (Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vaccines, Subunit Vaccines) Market by Disease Type (Canine Disease, Porcine Disease, Bovine Disease, Poultry Disease, Aquaculture Disease, Other Diseases) by Geography
The North America veterinary vaccines market growth is predicted to progress at a CAGR of 6.82% during the forecast period, 2022-2030, and generate a revenue of $5059.29 million by 2030.
The rising animal diseases contribute to increased demands for vaccines across North America. Also, pet owners and farm animal producers are taking effective measures like vaccination to tackle the disease spread. In addition, the growing R&D efforts by government/private research institutes and market players contribute to market prospects.
To know more about this report, request a free sample copy
The North America veterinary vaccines market growth evaluation includes the analysis of Canada and the United States. The United States has a 75.7 million swine population and 93.36 million cattle population. Such livestock is used for multiple purposes like meat production, dairy production, farming, etc. As a result, it becomes necessary for animal producers to ensure disease-free livestock to conduct business without hindrance in terms of revenue and resource losses. Accordingly, veterinary vaccines are increasingly prioritized, with various manufacturers launching vaccinated solutions.
Further, the regulatory agencies in the US have strict policies for restricting the spread of infection among humans and animals. In this regard, the agencies have adopted several strategies. For instance, the US banned dog imports from 113 countries in 2021 after an increase in false rabies records. Additionally, the CDC identified over 450 imported dogs with fraudulent rabies certificates in 2020. This constituted a 52% increase than the previous years. However, vaccination is a compulsory part of the routine healthcare plan for livestock and pet animals in the country. The other factors influencing the market growth in the US include the presence of prominent market players and the prevailing viral infections.
Whereas, in countries like Canada, vaccines to be sold are obligated to register with the Canadian Centre for Veterinary Biologics. The first DNA vaccines for edible species to protect Atlantic salmon from hematopoietic necrosis were registered in 2005. Also, the Veterinary Medical Association has amended vaccination protocols for dogs and cats. Additionally, most newborn calves are administered BVD and clostridial vaccines.
Further, in 2015, the International Development Research Centre established a Livestock Vaccines Innovation Fund to enhance the health of livestock and farmers’ livelihood by supplementing the commercialization, development, and production of innovative vaccines to tackle neglected livestock diseases in South-East and South Asia and Sub-Saharan Africa. Such developments, alongside innovations in new vaccines developments, are expected to contribute to the Canada market growth.
The North America veterinary vaccines market scope includes the analysis of three segments, namely, product type, disease type, and animal type. The animal type is further sub-segmented into aquaculture, companion animal, and livestock animal. Aquaculture is gaining traction in the animal type category. Aquaculture is the production of aquatic plants and animals under partially-controlled and managed conditions. Fishes are increasingly produced to meet the high consumer demands worldwide. The largest fish producers globally include Indonesia, India, and China. Also, the diseases associated with aquatic animals are Trichodiniasis, Enteric Red Mouth Disease, Saprolegniasis, etc.
Some of the prominent companies in the market include Brilliant Bio Pharma, Hester Biosciences Ltd, Ceva Sante Animale, Elanco Animal Health, etc.
Elanco Animal Health is a global animal health company that provides services and products to prevent and treat diseases in pets and farm animals. It provides a diverse portfolio of around 190 brands to farm animal producers and veterinarians in over 90 countries. The company has a presence in Asia-Pacific, the Middle East & Africa (EMEA), Latin America, and North America, with headquarters in Indiana, the US.
One of its products, Master Guard, is a combination of MLV and killed antigens that offers reproductive and respiratory protection for herd-including pregnant cows.
Report Synopsis
| Report Scope | Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue (Million) |
| Segments Analyzed | Product Type, Animal Type, Disease Type |
| Countries Analyzed | United States and Canada |
| Companies Analyzed | Boehringer Ingelheim International GmbH, Brilliant Bio Pharma, Ceva Sante Animale, Elanco Animal Health, Hester Biosciences Ltd, Hipra, Indian Immunologicals Limited, Merck Animal Health, Phibro Animal Health, Vaxxinova GmbH, Virbac SA, and Zoetis |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- RESEARCH & DEVELOPMENT OF ADVANCED VACCINES
- NEED OF VACCINE DUE TO RISING ANIMAL POPULATION AND DISEASES
- VACCINATION DRIVES BY GOVERNMENT AGENCIES
- KEY RESTRAINTS
- RULES & REGULATIONS FOR THE USE OF VACCINE
- LACK OF AWARENESS AMONG FARMERS AND REQUIREMENT OF SKILLED VETERINARIANS
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON VETERINARY VACCINES MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
- REGULATORY FRAMEWORK
- MARKET BY ANIMAL TYPE
- LIVESTOCK ANIMAL
- CATTLE
- PIGS
- POULTRY
- SHEEP
- OTHER LIVESTOCK ANIMALS
- COMPANION ANIMAL
- CANINE
- FELINE
- EQUINE
- AQUACULTURE
- LIVESTOCK ANIMAL
- MARKET BY PRODUCT TYPE
- ATTENUATED VACCINES
- INACTIVATED VACCINES
- TOXOID VACCINES
- CONJUGATE VACCINES
- DNA VACCINES
- RECOMBINANT VACCINES
- SUBUNIT VACCINES
- MARKET BY DISEASE TYPE
- CANINE DISEASE
- PORCINE DISEASE
- BOVINE DISEASE
- POULTRY DISEASE
- AQUACULTURE DISEASE
- OTHER DISEASES
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- BRILLIANT BIO PHARMA
- CEVA SANTE ANIMALE
- ELANCO ANIMAL HEALTH
- HESTER BIOSCIENCES LTD
- HIPRA
- INDIAN IMMUNOLOGICALS LIMITED
- MERCK ANIMAL HEALTH
- PHIBRO ANIMAL HEALTH
- VAXXINOVA GMBH
- VIRBAC SA
- ZOETIS
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – VETERINARY VACCINES
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: NORTH AMERICA VETERINARY VACCINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: NORTH AMERICA VETERINARY VACCINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: NORTH AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMAL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: NORTH AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMAL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA VETERINARY VACCINES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: NORTH AMERICA VETERINARY VACCINES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: NORTH AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: NORTH AMERICA VETERINARY VACCINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: NORTH AMERICA VETERINARY VACCINES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: LEADING PLAYERS OPERATING IN NORTH AMERICA VETERINARY VACCINES MARKET
TABLE 16: LIST OF MERGERS & ACQUISITIONS
TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: VALUE CHAIN ANALYSIS
FIGURE 4: KEY BUYING CRITERIA
FIGURE 5: NORTH AMERICA VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY ANIMAL TYPE, IN 2021
FIGURE 6: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, 2022-2030 (IN $ MILLION)
FIGURE 7: NORTH AMERICA VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY LIVESTOCK ANIMAL, IN 2021
FIGURE 8: NORTH AMERICA VETERINARY VACCINES MARKET, BY CATTLE, 2022-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA VETERINARY VACCINES MARKET, BY PIGS, 2022-2030 (IN $ MILLION)
FIGURE 10: NORTH AMERICA VETERINARY VACCINES MARKET, BY POULTRY, 2022-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA VETERINARY VACCINES MARKET, BY SHEEP, 2022-2030 (IN $ MILLION)
FIGURE 12: NORTH AMERICA VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2030 (IN $ MILLION)
FIGURE 13: NORTH AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMAL, 2022-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY COMPANION ANIMAL TYPE, IN 2021
FIGURE 15: NORTH AMERICA VETERINARY VACCINES MARKET, BY CANINE, 2022-2030 (IN $ MILLION)
FIGURE 16: NORTH AMERICA VETERINARY VACCINES MARKET, BY FELINE, 2022-2030 (IN $ MILLION)
FIGURE 17: NORTH AMERICA VETERINARY VACCINES MARKET, BY EQUINE, 2022-2030 (IN $ MILLION)
FIGURE 18: NORTH AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2030 (IN $ MILLION)
FIGURE 19: NORTH AMERICA VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
FIGURE 20: NORTH AMERICA VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2030 (IN $ MILLION)
FIGURE 21: NORTH AMERICA VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2030 (IN $ MILLION)
FIGURE 22: NORTH AMERICA VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2030 (IN $ MILLION)
FIGURE 23: NORTH AMERICA VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2030 (IN $ MILLION)
FIGURE 24: NORTH AMERICA VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2030 (IN $ MILLION)
FIGURE 25: NORTH AMERICA VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2030 (IN $ MILLION)
FIGURE 26: NORTH AMERICA VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2030 (IN $ MILLION)
FIGURE 27: NORTH AMERICA VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY DISEASE TYPE, IN 2021
FIGURE 28: NORTH AMERICA VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2030 (IN $ MILLION)
FIGURE 29: NORTH AMERICA VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2030 (IN $ MILLION)
FIGURE 30: NORTH AMERICA VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2030 (IN $ MILLION)
FIGURE 31: NORTH AMERICA VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2030 (IN $ MILLION)
FIGURE 32: NORTH AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2030 (IN $ MILLION)
FIGURE 33: NORTH AMERICA VETERINARY VACCINES MARKET, BY OTHER DISEASES, 2022-2030 (IN $ MILLION)
FIGURE 34: NORTH AMERICA VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 35: UNITED STATES VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: CANADA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY ANIMAL TYPE
- LIVESTOCK ANIMAL
- CATTLE
- PIGS
- POULTRY
- SHEEP
- OTHER LIVESTOCK ANIMALS
- COMPANION ANIMAL
- CANINE
- FELINE
- EQUINE
- AQUACULTURE
- LIVESTOCK ANIMAL
- MARKET BY PRODUCT TYPE
- ATTENUATED VACCINES
- INACTIVATED VACCINES
- TOXOID VACCINES
- CONJUGATE VACCINES
- DNA VACCINES
- RECOMBINANT VACCINES
- SUBUNIT VACCINES
- MARKET BY DISEASE TYPE
- CANINE DISEASE
- PORCINE DISEASE
- BOVINE DISEASE
- POULTRY DISEASE
- AQUACULTURE DISEASE
- OTHER DISEASES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.